Real-world clinical outcomes of patients with BRCA-mutated, human epidermal growth factor receptor 2 (HER2)-negative metastatic breast cancer: a CancerLinQ® study

PURPOSE: To investigate real-world clinical outcomes in patients with BRCA-mutated (BRCAm), HER2-negative metastatic breast cancer (mBC) according to BRCA and hormone receptor (HR) status. METHODS: Patients diagnosed with HER2-negative mBC between 01 January 2010 and 31 December 2018 were retrospect...

Descripción completa

Detalles Bibliográficos
Autores principales: Miller, Robert S., Mokiou, Stella, Taylor, Aliki, Sun, Ping, Baria, Katherine
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2022
Materias:
Clinical Trial
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8993712/
https://www.ncbi.nlm.nih.gov/pubmed/35194731
http://dx.doi.org/10.1007/s10549-022-06541-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8993712/
https://www.ncbi.nlm.nih.gov/pubmed/35194731
http://dx.doi.org/10.1007/s10549-022-06541-3

Ejemplares similares